Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYCLOPHOSPHAMIDE FOR , USP: 363 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
363
Total FAERS Reports
195 (53.7%)
Deaths Reported
19
Hospitalizations
363
As Primary/Secondary Suspect
1
Life-Threatening

First Report: 200909 · Latest Report: 201402

What Are the Most Common CYCLOPHOSPHAMIDE FOR , USP Side Effects?

#1 Most Reported
Death
73 reports (20.1%)
#2 Most Reported
Neoplasm progression
62 reports (17.1%)
#3 Most Reported
Disease progression
39 reports (10.7%)

All CYCLOPHOSPHAMIDE FOR , USP Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Death 73 20.1% 73 1
Neoplasm progression 62 17.1% 62 0
Disease progression 39 10.7% 6 0
Neutropenia 32 8.8% 21 0
Thrombocytopenia 23 6.3% 22 0
Exposure during pregnancy 21 5.8% 0 0
Acute graft versus host disease 20 5.5% 0 0
Leukaemia recurrent 18 5.0% 18 0
Disease recurrence 16 4.4% 13 0
No adverse event 15 4.1% 0 0
Liver function test abnormal 7 1.9% 0 0
Precursor t-lymphoblastic lymphoma/leukaemia recurrent 6 1.7% 0 0
Bacteraemia 5 1.4% 0 0
Chronic graft versus host disease 5 1.4% 0 0
Dehydration 5 1.4% 0 4
Foetal exposure during pregnancy 5 1.4% 1 0

Who Reports CYCLOPHOSPHAMIDE FOR , USP Side Effects? Age & Gender Data

Average age: 34.1 years. Most reports from: US. View detailed demographics →

Is CYCLOPHOSPHAMIDE FOR , USP Getting Safer? Reports by Year

YearReportsDeathsHosp.
2009 1 0 0
2010 1 0 0
2011 1 0 1
2012 2 0 2
2013 7 0 7
2014 3 0 2

View full timeline →

What Is CYCLOPHOSPHAMIDE FOR , USP Used For?

IndicationReports
Breast cancer 98
Acute leukaemia 25
Prophylaxis against graft versus host disease 25
Blast crisis in myelogenous leukaemia 21
Mantle cell lymphoma 21
Leukaemia 18
B-cell lymphoma 15
Plasma cell myeloma 14
Acute lymphocytic leukaemia 12
Diffuse large b-cell lymphoma 12

CYCLOPHOSPHAMIDE FOR , USP vs Alternatives: Which Is Safer?

CYCLOPHOSPHAMIDE FOR , USP vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOPHOSPHAMIDE FOR , USP vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE CYCLOPHOSPHAMIDE FOR , USP vs CYCLOSERINE CYCLOPHOSPHAMIDE FOR , USP vs CYCLOSPORINE CYCLOPHOSPHAMIDE FOR , USP vs CYCLOSPORINE A CYCLOPHOSPHAMIDE FOR , USP vs CYMBALTA CYCLOPHOSPHAMIDE FOR , USP vs CYNODON DACTYLON POLLEN CYCLOPHOSPHAMIDE FOR , USP vs CYPROHEPTADINE CYCLOPHOSPHAMIDE FOR , USP vs CYPROTERONE CYCLOPHOSPHAMIDE FOR , USP vs CYPROTERONE\ETHINYL ESTRADIOL

Official FDA Label for CYCLOPHOSPHAMIDE FOR , USP

Official prescribing information from the FDA-approved drug label.